Target intelligence / Profile preview

E2F transcription factor 3 pseudogene 2 (E2F3P2)

Target
E2F3P2
Molecular classification
Other, Pseudogene
01

Overview

E2F transcription factor 3 pseudogene 2 (E2F3P2) is a pseudogene in the human genome[3][1][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically do not encode a functional protein product and generally lack biological activity. E2F3P2 shares sequence similarity with E2F transcription factor 3 (E2F3), a true transcription factor involved in cell cycle regulation, but E2F3P2 itself does not function as a receptor, enzyme, or direct therapeutic target[3][1][5]. There is no evidence in the literature or gene databases of E2F3P2 serving as a target for drugs, being implicated in clear biological functions, or acting as a biomarker or mediator in disease. Some sources list a disease association with atrial fibrillation, but this appears to be an annotation error or only a bioinformatics association, with no validated mechanistic link[3]. Therefore, E2F3P2 is not a functional molecule in pharmacology or cellular signaling, and inclusion of this entry as a drug target would be considered incorrect[3][1][5].

Beyond the preview

Go deeper on E2F transcription factor 3 pseudogene 2 (E2F3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E2F transcription factor 3 pseudogene 2 (E2F3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call